CAR T cell therapy in solid tumors: A review of current clinical trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CAR T cell therapy in solid tumors: A review of current clinical trials

Published:2021-12-07 Issue:S1 Volume:3 Page:24-31
ISSN:2688-6146
Container-title:eJHaem
language:en
Short-container-title:eJHaem

Author:

Patel Urvi¹,Abernathy John²,Savani Bipin N³,Oluwole Olalekan³,Sengsayadeth Salyka³,Dholaria Bhagirathbhai³

Affiliation:

1. College of Pharmacy The University of Tennessee Health Science Center Nashville Tennessee USA

2. College of Medicine The University of Tennessee Health Science Center Memphis Tennessee USA

3. Department of Hematology‐ Oncology Vanderbilt‐Ingram Cancer Center Vanderbilt University Medical Center Nashville Tennessee USA

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jha2.356

Reference45 articles.

1. Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas

2. Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia

3. Global Registration Trial of Efficacy and Safety of CTL019 in Pediatric and Young Adult Patients with Relapsed/Refractory (R/R) Acute Lymphoblastic Leukemia (ALL): Update to the Interim Analysis

4. Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma

5. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011–2015

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EphA2 specific chimeric antigen receptor engineered T cells for the treatment of prostate cancer;Translational Oncology;2024-12

2. A Digital Microfluidic Platform for the Microscale Production of Functional Immune Cell Therapies;2024-09-08

3. Targeting endothelial cell anergy to improve CAR T cell therapy for solid tumors;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

4. Advancements in Immunotherapy for Breast Cancer: Mechanisms, Efficacy, and Future Directions;Cureus;2024-08-31

5. Advances in bioengineered CAR T/NK cell therapy for glioblastoma: Overcoming immunosuppression and nanotechnology‐based strategies for enhanced CAR T/NK cell therapy;Bioengineering & Translational Medicine;2024-08-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3